Reduction in proteinuria after immunosuppressive therapy and long-term kidney outcomes in patients with immunoglobulin A nephropathy

Reduction in proteinuria after immunosuppressive therapy and long-term kidney outcomes in patients with immunoglobulin A nephropathy

Background/Aims Despite controversy regarding the benefits of immunosuppressive therapy in immunoglobulin A nephropathy (IgAN), clinical outcomes may vary depending on the patient’s responsiveness to this therapy. This study evaluated long-term kidney outcomes according to the extent of proteinuria...

Full description

Bibliographic Details
Main Authors:	Shin Chan Kang, Hyung Woo Kim, Tae Ik Chang, Ea Wha Kang, Beom Jin Lim, Jung Tak Park, Tae-Hyun Yoo, Hyeon Joo Jeong, Shin-Wook Kang, Seung Hyeok Han
Format:	Article
Language:	English
Published:	The Korean Association of Internal Medicine 2021-09-01
Series:	The Korean Journal of Internal Medicine
Subjects:	immunoglobulin a nephropathy immunosuppression proteinuria
Online Access:	http://www.kjim.org/upload/pdf/kjim-2020-240.pdf

Similar Items

The Effect of Hydroxychloroquine on Residual Proteinuria in Patients With Immunoglobulin A Nephropathy: A Retrospective Study Based on Propensity Score Matching
by: Mijia Liu, et al.
Published: (2022-07-01)

Association of proteinuria with various clinical findings and morphologic variables of oxford classification in immunoglobulin a nephropathy patients
by: Hamid Nasri, et al.
Published: (2013-01-01)

Effect of hematuria on the outcome of immunoglobulin A nephropathy with proteinuria
by: Chihiro Iwasaki, et al.
Published: (2016-04-01)

A multicenter, randomized, open-label, comparative, phase IV study to evaluate the efficacy and safety of combined treatment with mycophenolate mofetil and corticosteroids in advanced immunoglobulin A nephropathy
by: Sang Youb Han, et al.
Published: (2022-07-01)

Effect of hydroxychloroquine in patients with IgA nephropathy with insufficient responses to immunosuppressive therapy: a retrospective case-control study
by: Chen Tang, et al.
Published: (2020-11-01)

Spot urine protein/creatinine ratio as a reliable estimate of 24-hour proteinuria in patients with immunoglobulin A nephropathy, but not membranous nephropathy
by: Seiji Kobayashi, et al.
Published: (2019-08-01)

Huai Qi Huang ameliorates proteinuria and hematuria in mild IgA nephropathy patients: A prospective randomized controlled study
by: Lei-Ting Li, et al.
Published: (2013-12-01)

Prevalence of persistent proteinuria in stable HIV/AIDS patients and its association with HIV nephropathy
by: Maria Alina Gomes de Mattos Cavalcante, et al.

A case report of immunoglobulin M nephropathy manifesting as crescentic glomerulonephritis and nephrotic syndrome in an adult
by: Kyoung Sook Park, et al.
Published: (2019-08-01)

EFFECTIVENESS OF IMMUNOSUPPRESSANTS ALONG WITH ACEI/ARBS IN TREATING PROTEINURIA IN PATIENTS WITH SOLITARY KIDNEY POST NEPHRECTOMY
by: Nadeem Azam, et al.
Published: (2018-10-01)

Role of corticosteroid therapy in IgA nephropathy; where do we stand?
by: Shankar Prasad Nagaraju, et al.
Published: (2017-10-01)

Perspective of personalized treatment of immunoglobulin A-nephropathy
by: K.S. Komissarov
Published: (2020-02-01)

Hyperuricemia as a marker for progression of immunoglobulin A nephropathy
by: Su-Ji Kim, et al.
Published: (2012-09-01)

Clinicopathological Features to Predict Progression of IgA Nephropathy with Mild Proteinuria
by: Ding Chen, et al.
Published: (2018-03-01)

Effect of SGLT2 inhibitors on the proteinuria reduction in patients with IgA nephropathy
by: Yaping Dong, et al.
Published: (2023-09-01)

Syphilis and Proteinuria in Pregnancy
by: Jay Jensen, et al.
Published: (2022-07-01)

Comparison of the effects of hydroxychloroquine and corticosteroid treatment on proteinuria in IgA nephropathy: a case-control study
by: Ya-zi Yang, et al.
Published: (2019-08-01)

Proteinuria,fisiología y fisiopatología aplicada
by: Carlos Escalante-Gómez, et al.
Published: (2007-04-01)

Clinicopathological Features and Outcomes of IgA Nephropathy with Hematuria and/or Minimal Proteinuria
by: Min Tan, et al.
Published: (2015-04-01)

Benazepril hydrochloride improves diabetic nephropathy and decreases proteinuria by decreasing ANGPTL-4 expression
by: Lingyu Xue, et al.
Published: (2017-10-01)

Nephropathy in a Child with Severe Recessive Dystrophic Epidermolysis Bullosa Treated with Cyclophosphamide: A Case Report
by: Cahyani Gita Ambarsari, et al.
Published: (2023-07-01)

Remission of Proteinuria May Protect against Progression to Chronic Kidney Disease in Pediatric-Onset IgA Nephropathy
by: Jin-Soon Suh, et al.
Published: (2020-06-01)

Comparison of two protocols for steroid pulse therapy in patients with IgA nephropathy: a retrospective observational study
by: Satoshi Yamatani, et al.
Published: (2022-04-01)

Impact of Proteinuria and Kidney Function Decline on Health Care Costs and Resource Utilization in Adults With IgA Nephropathy in the United States: A Retrospective Analysis
by: Edgar V. Lerma, et al.
Published: (2023-09-01)

Clinical significance of massive proteinuria in primary IgA nephropathy with and without nephrotic syndrome: a single center cohort study
by: Ya Hu, et al.
Published: (2023-12-01)

Outcomes of normotensive IgA nephropathy patients with mild proteinuria who have impaired renal function
by: Min Tan, et al.
Published: (2019-01-01)

Clinical practice pattern on hematuria and proteinuria in children: the report of a survey for the Korean Society of Pediatric Nephrology
by: Jeesu Min, et al.
Published: (2023-06-01)

Baseline proteinuria level is associated with prognosis in idiopathic membranous nephropathy
by: Xinxin Chen, et al.
Published: (2019-01-01)

Effects of Aggressive Approach to the Multiple Risk Factors for Diabetic Nephropathy on Proteinuria Reduction in Diabetes Type 2 Patients
by: Belma Aščić – Buturović, et al.
Published: (2009-02-01)

Efficacy and safety of tacrolimus-based treatment for non-rapidly progressive IgA nephropathy
by: Lijuan Zhao, et al.
Published: (2023-05-01)

A mixed-method evaluation of the relationship between Oxford classification scores and longitudinal changes in proteinuria in patients with immunoglobulin A nephropathy
by: Ri-Cong Xu, et al.
Published: (2023-01-01)

Monogenic Causes of Proteinuria in Children
by: Onur Cil, et al.
Published: (2018-03-01)

Microtubule associated protein 4 phosphorylation-induced epithelial-to-mesenchymal transition of podocyte leads to proteinuria in diabetic nephropathy
by: Lingfei Li, et al.
Published: (2022-07-01)

Plasma endocan level and prognosis of immunoglobulin A nephropathy
by: Yu Ho Lee, et al.
Published: (2016-09-01)

A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy
by: Ruijuan Dong, et al.
Published: (2020-10-01)

External validation of the international prediction tool in Korean patients with immunoglobulin A nephropathy
by: Young Su Joo, et al.
Published: (2022-09-01)

Use of corticosteroids in Norwegian patients with immunoglobulin a nephropathy progressing to end-stage kidney disease: a retrospective cohort study
by: Mariell Rivedal, et al.
Published: (2024-01-01)

Glomerulosclerosis is a prognostic risk factor in patients with membranous nephropathy and non-nephrotic proteinuria
by: Jing Sun, et al.
Published: (2023-12-01)

Anti-proteinuria effect of active vitamin D in patients with type 2 diabetic nephropathy
by: Asieh Aref, et al.
Published: (2022-01-01)

Immunoglobulin M nephropathy nephropathy in adults and adolescents in India: A single-center study of natural history
by: A M Singhai, et al.
Published: (2011-01-01)